Deep learning-based rapid generation of broadly reactive antibodies against SARS-CoV-2 and its Omicron variant

Cell Res. 2023 Jan;33(1):80-82. doi: 10.1038/s41422-022-00727-6. Epub 2022 Sep 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19*
  • Deep Learning*
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Viral
  • Antibodies, Neutralizing

Supplementary concepts

  • SARS-CoV-2 variants